Daiichi Sankyo stands as a prominent player in the realm of pharmaceuticals and biotechnology, driven by a commitment to innovation and excellence. Established in 2007, the company has been at the forefront of developing groundbreaking treatments and therapies to enhance patient outcomes globally. With a robust research and development framework, Daiichi Sankyo continues to push the boundaries of medical science.

Headquartered in Tokyo, Japan, the company employs a dedicated workforce of approximately 17,000 individuals. These employees are spread across various regions, working collaboratively to advance the company&#39;s mission of delivering innovative solutions in healthcare. The leadership under CEO Sunao Manabe has been pivotal in steering the company towards achieving significant milestones in drug discovery and development.

Daiichi Sankyo&#39;s portfolio includes a strong focus on oncology and cardiovascular therapies, addressing some of the most pressing health challenges worldwide. The company&#39;s strategic initiatives are designed to not only meet current healthcare needs but also anticipate future demands, ensuring a sustainable and impactful presence in the industry. With a steadfast commitment to patient-centricity and quality, Daiichi Sankyo continues to make a significant impact in the field of medicine.

Company

Daiichi Sankyo

AI Magazine

Business Chief Asia

Business Chief Middle East

Business Chief North America

Business Chief UK & Europe

ClimateTech Digital

Construction Digital

Cyber Magazine

Data Centre Magazine

EV Magazine

Energy Magazine

FinTech Magazine

Food and Drink Digital

Healthcare Digital

InsurTech Digital

Manufacturing Digital

March8

Mining Digital

Procurement Magazine

Scope 3 Magazine

Supply Chain Magazine

Sustainability Magazine

Technology Magazine

Telco Magazine

Features

Lists

Magazine

Videos

Content

About

Advertise

Mentorship

Accreditation

Editorial

More

Educate

Motivate

Elevate

News

Articles

Events

March8 Magazine

Magazines

How can we address gender bias and inequality in AI?

8 minutes with Amber Johnson, Global Vice President of Mars

Revealed: Top 5 US states with the most female-owned firms

B Corp: Are they really the gold standard of sustainability?

How to focus on the person behind the employee

Why gender diversity is key for the cyber-security industry

The value of bringing women into male-dominated industries